SCHEMBL15723273

SCHEMBL15723273

CC(C)c1cc(C(C)(C)C)cc(C2(C)COC2)c1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16440615 0.83 OGA (0.32) —
SCHEMBL15723272 0.73 — —
SCHEMBL377542 0.72 GABRA1 (0.48) —
SCHEMBL7085860 0.72 GABRA1 (0.42) —
SCHEMBL15723317 0.70 CCR2 (0.38) —
SCHEMBL12024951 0.70 KCNH2 (0.44) —
SCHEMBL19102418 0.70 KCNH2 (0.44) —
SCHEMBL15784643 0.66 — —
SCHEMBL7082656 0.65 POLB (0.38) —
SCHEMBL25468629 0.65 CA1 (0.39) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8946446-B2 Pyrrolo sulfonamide compounds for modulation of orphan nuclear receptor RAR-related orphan receptor-γ (ROR-γ, NR1F3) activity and for the treatment of chronic inflammatory and autoimmune diseases PHENEX PHARMACEUTICALS AG (DE) 2015-02-03 — — US disclosed
US-20140142082-A1 PYRROLO SULFONAMIDE COMPOUNDS FOR MODULATION OF ORPHAN NUCLEAR RECEPTOR RAR-RELATED ORPHAN RECEPTOR-GAMMA (ROR-GAMMA, NR1F3) ACTIVITY AND FOR THE TREATMENT OF CHRONIC INFLAMMATORY AND AUTOIMMUNE DISEASES PHENEX PHARMACEUTICALS AG (DE) 2014-05-22 — — US disclosed
Send feedback